4//SEC Filing
Aromando Andrew 4
Accession 0000950170-23-069448
CIK 0001990550other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:19 PM ET
Size
5.2 KB
Accession
0000950170-23-069448
Insider Transaction Report
Form 4
Aromando Andrew
Chief Operating Officer
Transactions
- Award
Common Stock
2023-12-11+100,000→ 109,263 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") payable in common stock of the Issuer granted to the Reporting Person on December 11, 2023 (the "Grant Date"). These RSUs were granted in connection with the completion of the year-end review process and will be issued pursuant to the Company's Amended and Restated 2021 Equity Incentive Plan.
- [F2]The RSUs will vest over thirty-six (36) months as follows: (i) one-sixth (1/6) of the RSUs will vest on the six (6)-month anniversary of the Grant Date, and (ii) one-twelfth (1/12) of the RSUs will vest on a quarterly basis thereafter.
Documents
Issuer
Ambrx Biopharma, Inc.
CIK 0001990550
Entity typeother
Related Parties
1- filerCIK 0001976455
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:19 PM ET
- Size
- 5.2 KB